Los Gatos, CA, United States of America

Marc Jensen

This inventor holds 20 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Proteus Digital Health, Inc., Medtronic Vascular, Inc., Pulsar Vascular, Inc.. Active years: 2003-2022.

USPTO Granted Patents = 20 

% Patents Active = 65.0

 

 

Average Co-Inventor Count = 5.4

ph-index = 16

Forward Citations = 1,811(Granted Patents)


Location History:

  • Los Gatos, CA (US) (2003 - 2022)
  • San Jose, CA (US) (2015 - 2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marc Jensen

Introduction

Marc Jensen is a prominent inventor based in Los Gatos, California, known for his significant contributions to medical technology. With a remarkable portfolio of 20 patents, Jensen has focused on developing devices and systems that address critical health issues, particularly in the field of vascular medicine.

Latest Patents

Among his latest innovations are two notable patents. The first patent, titled "Devices, systems and methods for enclosing an anatomical opening," describes technology aimed at enclosing anatomical openings, such as aneurysms. This device is designed to be delivered endovascularly to a site near an arterial aneurysm, featuring a closure structure that partially occludes the aneurysm while arching over the artery's lumina. The closure structure includes support and anchoring arms, along with a supplemental stabilizer that presses outward against the artery's luminal wall. Additionally, a barrier spans the closure structure's distal-facing aspect to further occlude the aneurysm neck.

The second patent, "Intrasaccular flow diverter for treating cerebral aneurysms," focuses on implants that serve as flow diverters for aneurysms. This invention includes a stabilizing frame for anchoring the implant and an occluding element that diverts blood flow from the aneurysm neck. The stabilizing frame consists of two parts, with one part anchoring within the aneurysm sac and the other against the blood vessel wall. The occluding element is strategically positioned to effectively occlude the aneurysm neck.

Career Highlights

Marc Jensen has worked with several notable companies in the medical technology sector, including Proteus Digital Health, Inc. and Medtronic Vascular, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in healthcare.

Collaborations

Throughout his career, Jensen has collaborated with esteemed professionals in the field, including Mark Zdeblick and Joshua Makower. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Marc Jensen's work exemplifies the spirit of innovation in medical technology. His patents reflect a commitment to improving patient outcomes through advanced medical devices. Jensen's contributions continue to shape the future of vascular medicine and inspire future inventors.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…